Related references
Note: Only part of the references are listed.Assessing the Relation Between Bone Marrow Signal Intensity and Apparent Diffusion Coefficient in Diffusion-Weighted MRI
Anwar R. Padhani et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom
Dariya Malyarenko et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Whole-Body Diffusion-Weighted MRI Compared With 18F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma
Firas Mosavi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls
Dow-Mu Koh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer
Nicolas Michoux et al.
CLINICAL IMAGING (2012)
Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T
Petra Muertz et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index
David Ulmert et al.
EUROPEAN UROLOGY (2012)
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Frederic E. Lecouvet et al.
EUROPEAN UROLOGY (2012)
Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer
Elizabeth R. Dennis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures
Xuan Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
The proliferation rate paradox in antimitotic chemotherapy
Timothy J. Mitchison
MOLECULAR BIOLOGY OF THE CELL (2012)
Prospective Evaluation of 99mTc MDP Scintigraphy, 18F NaF PET/CT, and 18F FDG PET/CT for Detection of Skeletal Metastases
Andrei Iagaru et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Bony metastases: assessing response to therapy with whole-body diffusion MRI
A.R. Padhani et al.
CANCER IMAGING (2012)
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Colleen M. Costelloe et al.
Journal of Cancer (2012)
The convergence of radiation and immunogenic cell death signaling pathways
Encouse B. Golden et al.
FRONTIERS IN ONCOLOGY (2012)
The CT flare response of metastatic bone disease in prostate cancer
Christina Messiou et al.
ACTA RADIOLOGICA (2011)
Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology
Jens Hillengass et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Prospective Analysis of Parametric Response Map-Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment
Craig J. Galban et al.
CLINICAL CANCER RESEARCH (2011)
Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
Charles J. Ryan et al.
CLINICAL CANCER RESEARCH (2011)
Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
Hannah M. Linden et al.
CLINICAL CANCER RESEARCH (2011)
Utilizing circulating tumor cells: challenges and pitfalls
Gerhardt Attard et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
F-18-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging
Michael McCarthy et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Assessing response in bone metastases in prostate cancer with diffusion weighted MRI
C. Messiou et al.
EUROPEAN RADIOLOGY (2011)
Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
C. Messiou et al.
EUROPEAN RADIOLOGY (2011)
Whole-Body MRI Including Diffusion-Weighted Imaging (DWI) for Patients With Recurring Prostate Cancer: Technical Feasibility and Assessment of Lesion Conspicuity in DWI
Matthias Eiber et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
Diffusion-Weighted MR Imaging in Pancreatic Endocrine Tumors Correlated With Histopathologic Characteristics
Yi Wang et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
Diagnostic Value of Whole-Body Magnetic Resonance Imaging for Bone Metastases: A Systematic Review and Meta-Analysis
Lian-Ming Wu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
Prostate Cancer: PET with F-18-FDG, F-18- or C-11-Acetate, and F-18- or C-11-Choline
Hossein Jadvar
JOURNAL OF NUCLEAR MEDICINE (2011)
Diffusion MR Imaging for Monitoring of Treatment Response
Anwar R. Padhani et al.
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA (2011)
Computed Diffusion-weighted MR Imaging May Improve Tumor Detection
Matthew D. Blackledge et al.
RADIOLOGY (2011)
Whole-Body Diffusion-weighted MR Imaging in Cancer: Current Status and Research Directions
Anwar R. Padhani et al.
RADIOLOGY (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer
Arda Kayhan et al.
WORLD JOURNAL OF RADIOLOGY (2011)
Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
T. Hamaoka et al.
BRITISH JOURNAL OF CANCER (2010)
New molecular targets in bone metastases
D. Santini et al.
CANCER TREATMENT REVIEWS (2010)
Novel Bone-Targeted Strategies in Oncology
Sonia Vallet et al.
CLINICAL CANCER RESEARCH (2010)
Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis
G. Y. Tang et al.
CLINICAL RADIOLOGY (2010)
Diffusion and perfusion imaging of bone marrow
Andreas Biffar et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
18F-FDG PET/CT Findings and Circulating Tumor Cell Counts in the Monitoring of Systemic Therapies for Bone Metastases from Breast Cancer
Ugo De Giorgi et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Bone Metastases from Prostate Cancer: Assessing Treatment Response by Using Diffusion-weighted Imaging and Functional Diffusion Maps-Initial Observations
Carolin Reischauer et al.
RADIOLOGY (2010)
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma
Andreas Gutzeit et al.
SKELETAL RADIOLOGY (2010)
Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR Images
Roka Namoto Matsubayashi et al.
JOURNAL OF ONCOLOGY (2010)
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
D. Olmos et al.
ANNALS OF ONCOLOGY (2009)
Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer
Bashar Zelhof et al.
BJU INTERNATIONAL (2009)
Whole-body MRI for the staging and follow-up of patients with metastasis
Gerwin P. Schmidt et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Imaging response to systemic therapy for bone metastases
Tobias Baeuerle et al.
EUROPEAN RADIOLOGY (2009)
Diffusion-Weighted Magnetic Resonance Imaging of Uterine Cervical Cancer
Ying Liu et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Circulating Tumor Cells: Evolving Evidence and Future Challenges
Efrat Dotan et al.
ONCOLOGIST (2009)
MR Imaging Insights into Skeletal Maturation: What Is Normal?
Tal Laor et al.
RADIOLOGY (2009)
Prostate Cancer: Role of SPECT and PET in Imaging Bone Metastases
Mohsen Beheshti et al.
SEMINARS IN NUCLEAR MEDICINE (2009)
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
[Anonymous]
NEOPLASIA (2009)
MR Imaging of Bone Metastases and Choice of Sequence: Spin Echo, In-Phase Gradient Echo, Diffusion, and Contrast Medium
Daniel Vanel et al.
SEMINARS IN MUSCULOSKELETAL RADIOLOGY (2009)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dixon techniques for water and fat imaging
Jingfei Ma
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
Tumor receptor imaging
David A. Mankoff et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women
F. A. Syed et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T
G. Manenti et al.
RADIOLOGIA MEDICA (2008)
Tumors in pediatric patients at diffusion-weighted MR imaging: Apparent diffusion coefficient and tumor cellularity
Paul D. Humphries et al.
RADIOLOGY (2007)
Magnetic resonance imaging of bone marrow in oncology, Part 1
Sinchun Hwang et al.
SKELETAL RADIOLOGY (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Vertebral marrow fat content and diffusion and-perfusion indexes in women with varying bone density: MR evaluation
James F. Griffith et al.
RADIOLOGY (2006)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Chemotherapeutic approaches for targeting cell death pathways
M. Stacey Ricci et al.
ONCOLOGIST (2006)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: Dynamic contrast-enhanced MR imaging and spectroscopy
JF Griffith et al.
RADIOLOGY (2005)
Positron emission tomography and bone metastases
I Fogelman et al.
SEMINARS IN NUCLEAR MEDICINE (2005)
Bisphosphonates for breast cancer
N Pavlakis et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Assessment of therapeutic response in patients with metastatic bone disease
A Clamp et al.
LANCET ONCOLOGY (2004)
Bone imaging in metastatic breast cancer
T Hamaoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Death by design: apoptosis, necrosis and autophagy
AL Edinger et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
The new bisphosphonate, Zometa((R)) (Zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: A comparison to pamidronate
A Lipton et al.
CANCER INVESTIGATION (2002)
Acute vertebral body compression fractures: discrimination between benign and malignant causes using apparent diffusion coefficients
JHM Chan et al.
BRITISH JOURNAL OF RADIOLOGY (2002)
Blood perfusion of vertebral lesions evaluated with gadolinium-enhanced dynamic MRI: In comparison with compression fracture and metastasis
WT Chen et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)
Vertebral bone marrow perfusion evaluated with dynamic contrast-enhanced MR imaging: Significance of aging and sex
WT Chen et al.
RADIOLOGY (2001)
Relationship between bone marrow cellularity and apparent diffusion coefficient
Y Nonomura et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2001)
Normal lumbar vertebrae: Anatomic, age, and sex variance in subjects at proton MR spectroscopy - Initial experience
D Schellinger et al.
RADIOLOGY (2000)
Analysis of diffusion changes in posttraumatic bone marrow using navigator-corrected diffusion gradients
R Ward et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2000)
Share Paper
